drugset / Trial / NCT05498103
Use of Methazolamide to Lower Intraocular Pressure
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the effect of methazolamide, 25 mg or 50 mg tablets once a day for a week than twice a day for a week, on lowering intraocular pressure and the safety of methazolamide.
Timeline
- Start
- 2023-02-17
- Primary completion
- 2023-09-14
- Completion
- 2024-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methazolamide | Small molecule | 25 mg | — |
| Comparator | Methazolamide | Small molecule | 50 mg | — |